Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Cardiorespiratory Effects of Smoke Fine Particulate Matter From Wildfires Can Persist for Months

The cardiorespiratory effects of smoke fine particulate matter (PM2.5), a primary wildfire emission that can spike for months after a wildfire begins, can persi

ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) yi

Odds of Advanced Cancer, Breast Cancer Death Lower in Screen-Detected Disease

For patients aged 40 years or older, screen-detected breast cancer is associated with lower odds of advanced cancer, mastectomy, and breast cancer-related death

New Sugar-Based Test Can Suss Out Snake Venoms

THURSDAY, June 5, 2025 Sweet Synthetic sugars could be key to sussing out what type of snake venom is threatening a person s life, researchers say.Specifically,

Crisis Pregnancy Centers Draw Fair Share of Younger Women, Study Says

THURSDAY, June 5, 2025 As many as 1 in 5 women say they ve sought care at fake medical clinics with an anti-abortion agenda, a new study says.Between 12 to 20 o

Naps Associated With Increased Risk Of Death

THURSDAY, June 5, 2025 An afternoon snooze might seem appealing to middle-aged folks and seniors, but these naps could carry a high cost.People with certain typ

Jail Time Increases A Person's Risk of Death

THURSDAY, June 5, 2025 Jail time has a huge effect on both an individual s and a community s long-term health, even after their release, a new study says.People

Weight Stigma Tied To Lingering Depression, Anxiety After Weight-Loss Surgery

THURSDAY, June 5, 2025 People who get weight-loss surgery experience an improvement in their mental health, but not because of the weight they lose, a new study

Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)

Cellectar Biosciences, Inc. (NASDAQ CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment o

Popular Keywords